Cannabis for Autism Adult Patients
Discover how cannabis can be a potential treatment option for adult patients with autism.
Discover how cannabis can be a potential treatment option for adult patients with autism.
Navigating the legal and practical aspects of obtaining cannabis for an autistic child can be complex. This guide provides a clear path to ensure you're making informed decisions.
Side effects of cannabis for autism: what shows up most, which risks matter, who is more vulnerable, and what to track if you try it.
Discover the benefits of medical cannabis for autism spectrum disorder and how to make an informed purchase.
No standard cannabis dose exists for autism. What small trials used, how titration works, and why CBD-dominant products are dosed by weight.
No single strain is "good for autism." See what caregivers actually look for: CBD:THC ratio, lab testing, dosing control, and clinician guidance.
Cannabis and autism research is early and mixed. Judge products by batch lab testing, CBD to THC ratio, milligram dosing, and clinician oversight.
CBD is not approved for autism behaviors. Learn what the evidence shows, the safety checks to run, and how to evaluate a product before the first dose.
Early studies and parent reports suggest CBD may ease anxiety and sleep problems in autism. No cannabis product is approved to treat autism, and the evidence is thin.
A practical guide to cannabis oil for autism in children: what to look for, how it's made, and what to expect from shipping and returns.
DEA docket DEA-2024-0059 drew tens of thousands of comments on moving cannabis to Schedule III. Convenience is not a statutory scheduling factor.
A clear look at the cannabis rescheduling timeline, from HHS review to DEA proposed rule, and what still has to happen.
This comparison review explores the shift in cannabis policies, focusing on how convenience has become a key factor in the debate between rescheduling and legalization.
Rescheduling cannabis to Schedule III would lift the 280E tax burden, not set federal retail prices. Learn how to time purchases and what to check.
Stay informed on the current status of cannabis rescheduling in the United States and understand its implications.
Stay updated on the latest news regarding the rescheduling of cannabis in the United States.
Learn how the rescheduling of cannabis has impacted laws and regulations in the United States.
Cannabis Schedule III is classified under the Controlled Substances Act, indicating it has a moderate to low potential for abuse and physical dependence.
How the DEA cannabis rescheduling hearing works, who takes part, the order of events, and what the final decision actually changes.
In 2024 the DEA proposed moving cannabis to Schedule III. The rule was not final. Here is what changed, what did not, and how to read the next headline.